Could cannabidiol (CBD) help increase survival rates among cancer patients? According to a study published in the journal Oncogene, there is a strong possibility. Conducted by researchers from the Queen Mary University of London, the study examined survival rates among mice suffering from pancreatic cancer. The mice were split into three group: mice receiving no treatment, mice that were given the chemotherapy drug Gemcitabine, and mice that were given a combination of both Gemcitabine and CBD. Mice that were given both CBD and Gemcitabine lived on average for 56 days, whereas mice that were given only Gemcitabine or no treatment at all survived for less than 30 days.
To read more, please visit the original post at The Independent.